ARCHIVES

FDA Approves Bayer’s Xofigo For Late-Stage Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

Centers Agree To Broader Phase 1 Availability; Cool to Idea Of Distributing Group C Drugs

November 16, 1990

“Forward Funding” Will Cost NCI $38 Million, 270 Grants, As OMB Legally Impounds FY 1985 Money

February 1, 1985

FDA Proposes New User Fees for Generics and Biosimilar Products

January 20, 2012

Breast Cancer Progress Report Summaries

November 14, 1975

FDA Forms Office of Combination Products;

January 10, 2003

“We Will Move Forward With Bold Expectations,” NCI Director Says

October 2, 1998